Related Experiment Videos

Degradation of penicillin-binding protein 2' in methicillin-resistant Staphylococcus aureus

Y Sumita1, M Fukasawa, S Mitsuhashi

  • 1Episome Institute, Gunma, Japan.

Chemotherapy
|May 1, 1995
PubMed

Insights

Researchers identified a novel 60-kD protein in methicillin-resistant Staphylococcus aureus. This protein is a degradation product of penicillin-binding protein 2' (PBP2'), linked to beta-lactam resistance mechanisms.

Area of Science:

  • Microbiology
  • Biochemistry
  • Molecular Biology

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant public health threat.
  • Penicillin-binding proteins (PBPs) are key targets for beta-lactam antibiotics.
  • Penicillin-binding protein 2' (PBP2') is crucial for MRSA survival and beta-lactam resistance.

Purpose of the Study:

  • To investigate the nature of a novel protein detected in MRSA with [14C]benzylpenicillin binding capacity.
  • To elucidate the relationship between this novel protein and PBP2' in MRSA.

Main Methods:

  • Utilized high concentrations of [14C]benzylpenicillin (PCG) and extended reaction times for detection.
  • Analyzed protein bands using fluorography to assess binding capacity and molecular mass.
  • Correlated the appearance of the novel protein with changes in PBP2' band density.

Main Results:

  • A novel 60-kD protein with [14C]PCG-binding capacity was detected in MRSA.
  • The band density of PBP2' decreased over time, correlating with the appearance of the 60-kD protein.
  • Binding profiles of beta-lactams for PBP2' and the 60-kD protein were consistent.

Conclusions:

  • The 60-kD protein is likely a degradation product of PBP2'.
  • This finding provides insights into the stability and potential modification of PBP2' in MRSA.
  • Understanding PBP2' degradation may offer new avenues for combating MRSA infections.

Related Concept Videos